公開日期 | 標題 | 作者 | 來源出版物 | WOS | 全文 |
2011 | Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation | Laport, G. G.; Sheehan, K.; Baker, J.; Armstrong, R.; Wong, R. M.; Lowsky, R.; Johnston, L. J.; Shizuru, J. A.; Miklos, D.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S. | Biology of Blood and Marrow Transplantation | | |
2017 | Determination of molecular remission in patients with mycosis fungoides (MF) and Sezary Syndrome (SS) following allogeneic transplant using high throughput sequencing (HTS) | Almazan, T.; Armstrong, R.; Kim, Y. H.; Weng, W. | Journal of Investigative Dermatology | | |
2015 | Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms | Narayan, R.; Benjamin, J.; Laport, G.; Tian, L.; Tate, K.; Elder, L.; Galvez, L.; Armstrong, R.; Sheehan, K.; Lowsky, R.; Arai, S.; Johnston, L.; Miklos, D.; Muffly, L. S.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Strober, S.; Negrin, R.; Meyer, E. | Blood | | |
2013 | Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility | Benjamin, J.; Laport, G. G.; Tate, K.; Galvez, L.; Armstrong, R.; Sheehan, K.; Arai, S.; Lowsky, R.; Johnston, L.; Miklos, D. B.; Shizuru, J.; Wen-Kai Weng ; Negrin, R. | Blood | | |
2011 | Efficient and reliable skin responses with unconventional low-dose total skin electron beam therapy in mycosis fungoides: A phase II study | Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Weng, W.; Sundram, U.; Dabaja, B.; Singh, L.; Duvic, M.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | |
2015 | Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2 | Ungewickell, A.; Bhaduri, A.; Rios, E.; Reuter, J.; Lee, C. S.; Mah, A.; Zehnder, A.; Ohgami, R.; Kulkarni, S.; Armstrong, R.; Wen-Kai Weng ; Gratzinger, D.; Tavallaee, M.; Rook, A.; Snyder, M.; Kim, Y.; Khavari, P. A. | Nature Genetics | | |
2012 | Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | |
2011 | Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Blood | | |
2011 | High throughput RNA sequencing of Sezary syndrome and cutaneous squamous cell carcinoma | Lee, C.; Qu, K.; Webster, D.; Kretz, M.; Mah, A.; Ungewickell, A.; Armstrong, R.; Weng, W.; Kim, Y.; Chang, H.; Khavari, P. | Journal of Investigative Dermatology | | |
2012 | The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients | Kelly-Sell, M. J.; Kim, Y. H.; Straus, S.; Benoit, B.; Harrison, C.; Sutherland, K.; Armstrong, R.; Wen-Kai Weng ; Showe, L. C.; Wysocka, M.; Rook, A. H. | American Journal of Hematology | | |
2018 | Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation | Muffly, L.; Sheehan, K.; Armstrong, R.; Jensen, K.; Tate, K.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood Advances | | |
2013 | Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Desmarais, C.; Hoppe, R.; Kim, Y. H. | Science Translational Medicine | | |
2014 | Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Benjamin, J. E.; Negrin, R. S.; Reddy, S.; Million, L.; Hoppe, R. T.; Kim, Y. H. | Blood | | |
2016 | Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation | Muffly, L. S.; Sheehan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | |
2018 | Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells | Meyer, E.; Laport, G. G.; Tantsura, I.; Tang, S. W.; Sahaf, B.; Rangarajan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Sheehan, K.; Arai, S.; Johnston, L.; Muffly, L.; Lowsky, R.; Rezvani, A.; Wen-Kai Weng ; Miklos, D.; Negrin, R. S. | Biology of Blood and Marrow Transplantation | | |
2015 | Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project | Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; Hoppe, R. T.; Nguyen-Lin, A.; Wen-Kai Weng ; Armstrong, R.; Pulitzer, M.; Advani, R. H.; Horwitz, S. M. | Journal of Clinical Oncology | | |
2011 | A prospective trial of low-dose total skin electron beam therapy in mycosis fungoides and proposal of a new clinically meaningful endpoint | Bashey, S.; Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Wen-Kai Weng ; Sundram, U.; Kim, Y. H.; Hoppe, R. | Journal Der Deutschen Dermatologischen Gesellschaft | | |
2012 | Transcriptome sequencing in Sezary Syndrome identifies novel Sezary cell-associated transcripts | Lee, C.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D.; Armstrong, R.; Weng, W.; Aros, C.; Mah, A.; Kretz, M.; Kim, Y. H.; Khavari, P. A. | Journal of Investigative Dermatology | | |
2012 | Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts | Lee, C. S.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D. E.; Armstrong, R.; Wen-Kai Weng ; Aros, C. J.; Mah, A.; Chen, R. O.; Lin, M. H.; Sundram, U.; Chang, H. Y.; Kretz, M.; Kim, Y. H.; Khavari, P. A. | Blood | | |
2019 | Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients | Meyer, E. H.; Laport, G.; Xie, B. J.; MacDonald, K.; Heydari, K.; Sahaf, B.; Tang, S. W.; Baker, J.; Armstrong, R.; Tate, K.; Tadisco, C.; Arai, S.; Johnston, L.; Lowsky, R.; Muffly, L.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Sheehan, K.; Miklos, D.; Negrin, R. S. | Jci Insight | | |